Rheumatology Author Prof György Nagy: EULAR
Professor György Nagy from the Semmelweis University, Hungry. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor György Nagy discusses his latest paper o...
27 Jan 202125min
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
Professor Philip Mease from the University of Washington School of Medicine. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Professor Philip Mease discusses hi...
18 Jan 202124min
Discussing Rheumatology: JAKi and TNFi
Prof Iain McInnes discusses JAK inhibitors and TNFi in RA treatment. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in ...
18 Jan 202110min
Perspectives In Inflammation - Professor Weinblatt
In this podcast the Past President of ACR, Professor Michael Weinblatt discusses his involvement in the development of methotrexate and the expansion of his unit at the Brigham, alongside Professor Pa...
11 Jan 202128min
Rheumatology Author Prof Josef Smolen: Barcitinib
Prof Josef Smolen from Medical University of Vienna. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Josef Smolen discusses efficacy of baricitinib in patie...
6 Jan 202140min
Rheumatology Author Dr Kerschbaumer: JAKinibs
Dr Andreas Kerschbaumer from Vienna University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Andreas Kerschbaumer discusses his systematic review paper on ...
29 Dec 202022min
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
Professor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib a...
29 Dec 202020min
Rheumatology Author Prof Kevin Winthrop: Tofacitinib
Prof Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib
22 Dec 202021min
